REACT Clinical Trial Lung Cancer Detection Study

REACT Clinical Trial - A Case-Finding Trial Utilizing A Risk Stratification Protocol Involving A Genetic Susceptibility Test and Computed Tomography Screening for Identifying Lung Cancer Prevalence In Current or Prior Smokers

Summary

El Camino Hospital is offering a research study that includes a genetic test linked with other risk factors which could determine the likelihood of having lung cancer. Participants who are current smokers will receive smoking cessation counseling. All participants will undergo a low dose (CT) computed tomography image of the chest.

Basic Eligibility Criteria:

• Age 50 or older
• Current smoker or ex-smoker
• Willing to participate in smoking cessation counseling if actively smoking
• Have no symptoms or history of lung cancer
• Previous cancer ok if no evidence of disease for > 5 years (current non-melanoma skin cancer or carcinoma in situ of the cervix ok)
• Have smoked the equivalent of 20 cigarettes per day for 20 years
• Are able to receive CT scans
• Are not pregnant
• Are able to swallow pills

Contact Information
For more information please call 650-988-7623.